Julie DiCarlo

Nessuna posizione attualmente

Health Technology

Consumer Services

Precedenti posizioni note di Julie DiCarlo

Società	Posizione	Inizio	Fine
AKILI, INC.	Public Communications Contact	01/09/2019	-
PURETECH HEALTH PLC	Contatto Relazioni con gli Investitori	-	-
PURETECH HEALTH PLC	Public Communications Contact	-	-
EPIZYME, INC.	Contatto Relazioni con gli Investitori	02/08/2016	-
EPIZYME, INC.	Public Communications Contact	02/08/2016	-
CUBIST PHARMACEUTICALS INC	Public Communications Contact	-	-

Towson University

Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Public Communications Contact	4
Investor Relations Contact	2
Undergraduate Degree	1

Settori

Health Technology	5
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
PURETECH HEALTH PLC	Health Technology
AKILI, INC.	Health Technology

Aziende private	2
Cubist Pharmaceuticals LLC Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA.	Health Technology
Epizyme, Inc. Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.	Health Technology

Aziende private

Health Technology